Translate this page into:
There is more to the “intracellular yeasts” than meets the eye
Corresponding author: Dr. Gagandeep Singh, Department of Microbiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029, India. drgagandeep@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Singh G, Xess I, Sachdev J. There is more to the “intracellular yeasts” than meets the eye. Indian J Dermatol Venereol Leprol 2021;87:62.
Sir,
We read with interest the article by Sondhi et al.1 regarding a case of disseminated histoplasmosis in a 69-year-old man- with the involvement of the face and larynx. The basic tool for establishing the diagnosis was a histopathological examination of the tissue. As per our classic teaching in mycology, intracellular yeasts ranging in size between 2–4 µ, may be seen in histoplasmosis, talaromycosis (with transverse septum), a small variant of blastomycosis, rarely cryptococcosis and Candida glabrata. The clinical picture in all these may vary. However, recently a new dimorphic fungus, Emergomyces spp., has been described that has clinical features and histopathological characters (yeast cells with narrow-based budding) similar to histoplasmosis.2
Emergomyces belongs to the larger family of thermally dimorphic fungi Ajellomycetaceae (Onygenales). The genus Emergomyces contains Es. africanus, Es. europaeus, Es. canadensis, Es. orientalis, and Es. pasteurianus. Es. africanus may present with localized cutaneous lesions (papules, nodules, ulcers) or pulmonary manifestations (chest X-ray abnormalities like diffuse reticulonodular disease, consolidation, effusions and/or lymphadenopathy), which are most common, while gastrointestinal tract, liver, lymph nodes and bone marrow are less commonly involved.3 All reported cases of other species have involved disseminated disease. Whether localized or disseminated, emergomycosis is almost always seen in immunocompromised patients (HIV infection, solid organ transplantation, hematological malignancies, immunosuppressant therapy)3 Since 2016, two cases of emergomycosis have been reported from India.4 It is also interesting to note that since it was first described, HIV-associated emergomycosis has become the most common endemic mycosis in South Africa.4
Therefore, for a complete understanding of the epidemiology of endemic mycosis, it is advisable to identify all intracellular yeasts by sequencing the internal transcribed spacer region of rDNA, beta-tubulin, actin and intein pre-mRNA-processing-splicing factor- 8 (PRP8).
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
- A case of disseminated histoplasmosis presenting with facial and laryngeal involvement. Indian J Dermatol Venereol Leprol. 2020;86:470.
- [CrossRef] [PubMed] [Google Scholar]
- Emergomycosis (Emergomyces africanus) in advanced HIV disease. Dermatopathology (Basel). 2019;6:63-9.
- [CrossRef] [PubMed] [Google Scholar]
- Emergomyces: The global rise of new dimorphic fungal pathogens. PLoS Pathog. 2019;15:e1007977.
- [CrossRef] [PubMed] [Google Scholar]
- Disseminated Emergomyces pasteurianus infection in India: A case report and a review. Mycopathologia. 2020;185:193-200.
- [CrossRef] [PubMed] [Google Scholar]